Members
FACCNE Members Release a Landmark Guide for Biotech and Pharma Leaders
Introducing "The Thriving Biopharma Business: How to Unlock Value and Drive Success in Biotech and Pharma" by Alain Eudaric & Jean-Noël Pellegrin
A “How to” Guide for Global Biopharma
FACCNE is proud to spotlight the publication of a major new reference work authored by two of our own members: Alain Eudaric, FACCNE Board Member, and Jean-Noël Pellegrin. A definitive guide for senior executives and entrepreneurs navigating the new business imperatives of the biopharma industry.
Critics’ Reviews
"A practical, straight-to-the-point guide for biotech leaders. It covers everything from valuation to partnerships—knowledge you don’t
learn in a lab."; Adrien Châtillon, CEO and Serial Entrepreneurin Neuroscience
"Congratulations on this book — a rare and insightful work that demystifies business development / mergers & acquisitions in biopharma"; Loïc Gonnet, Global Head of Mergers &Acquisitions at Sanofi
"A well-rounded and insightful book that covers key aspects of the biopharma industry. A great
resource for both experienced professionals and those just starting out"; Naji Gehchan, MD, MBA, Chief Medical & Development Officer I, Former Head of Global Development at Eli Lilly
What This Book Offers
- Practical approaches and models for high‑stakes deals: valuation, IP strategy, and regulatory dynamics
- Strategic guidance for biopharma: innovation, competitive advantage, corporate and asset strategies
- Concrete tools for financing, pitching, and leading in uncertain markets
- One-stop reference from strategy to storytelling, to negotiating, to deal contract structures, and cross‑border regulatory considerations
- Numerous real‑world case studies, frameworks, and illustrations.
